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The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the 
effects of canabinoids 
Abstract 
Cannabis increases the risk of schizophrenia in genetically vulnerable individuals. In this study we aim to 
show that the schizophrenia susceptibility gene neuregulin 1 (Nrg1) modulates the development of 
tolerance to cannabinoids in mice. Nrg1 heterozygous (HET) and wild-type (WT) mice were treated daily 
for 15 d with the synthetic analogue of D9-tetrahydrocannabinol, CP55,940 (0.4 mg/kg). We measured the 
impact of this exposure on locomotor activity, anxiety, prepulse inhibition (PPI), body temperature and 
FosB/DFosB immunohistochemistry. Tolerance to CP55,940-induced hypothermia and locomotor 
suppression developed more rapidly in Nrg1 HET mice than WT mice. Conversely in the light-dark test, 
while tolerance to the anxiogenic effect of CP55,940 developed in WT mice over days of testing, Nrg1 
hypomorphs maintained marked anxiety even after 15 d of treatment. Repeated cannabinoid exposure 
selectively increased FosB/DFosB expression in the lateral septum, ventral part (LSV) of Nrg1 HET but not 
WT mice. On day 1 of exposure opposite effects of CP55,940 treatment were observed on PPI, i.e. it was 
facilitated in Nrg1 hypomorphs and impaired in WT mice, despite the drug significantly impairing the 
acoustic startle reflex equally in both genotypes. These effects of CP55,940 on PPI were not maintained 
as both genotypes became tolerant to cannabinoid action with repeated exposure. Our results highlight 
that Nrg1 modulates the development of cannabinoid tolerance dependent on the parameter being 
measured. Furthermore, these data reinforce the notion that the VLS is an important brain region involved 
in Nrg1–cannabinoid interactions. 
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